Related Experiment Video
Updated: Jun 9, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Evolution of left ventricular thrombus on serial cardiovascular magnetic resonance imaging
Parag Bawaskar1, Abel A Hooker Mendez1, Pal Satyajit Singh Athwal1
1Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, 420 Delaware Street SE, MMC 508, Minneapolis, MN 55455, USA.
Insights
Left ventricular (LV) thrombus resolution is slower than previously thought, with significant embolic risk persisting beyond six months, especially in patients with unresolved thrombus. Extended anticoagulation is recommended.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Thrombosis Research
Background:
- Current management of left ventricular (LV) thrombus lacks robust data, relying on older echocardiography studies.
- Embolic risk and thrombus evolution patterns are poorly understood.
- Cardiovascular magnetic resonance imaging (CMR) is the gold standard for LV thrombus detection.
Purpose of the Study:
- To investigate the evolution of left ventricular (LV) thrombus using serial cardiovascular magnetic resonance imaging (CMR).
- To identify factors associated with the lack of thrombus resolution.
- To assess the embolic risk related to LV thrombus resolution status.
Main Methods:
- Retrospective cohort study of 107 patients with LV thrombus.
- Serial CMR scans performed at a median of 255 days post-diagnosis.
- Survival analysis using landmark methods to evaluate embolic events.
Main Results:
- A significant proportion of LV thrombi remained unresolved at 3, 6, and 12 months post-CMR detection (75%, 53%, and 37%, respectively).
- Factors associated with no resolution included myocardial infarction history, LV aneurysm, ischemic cardiomyopathy, and larger thrombus volume.
- Embolic events were more frequent beyond 6 months, particularly in patients with unresolved LV thrombus.
Conclusions:
- LV thrombus resolution rates are lower than previously reported, with substantial embolic risk persisting beyond 6 months.
- Unresolved LV thrombus on serial CMR is linked to increased embolic risk.
- Extended anticoagulation is warranted for patients with markers of poor LV thrombus resolution.
Aims:
Current management of left ventricular (LV) thrombus relies on limited, non-contemporary, echocardiography-based studies. Data on LV thrombus evolution and the associated embolic risk are scarce. We aimed to describe the evolution of LV thrombus on serial cardiovascular magnetic resonance imaging (CMR)-the current reference standard for the detection of LV thrombus-and identify correlates of no resolution and the embolic risk associated with resolution status.
Methods And Results:
We conducted a retrospective cohort study of 107 consecutive patients with LV thrombus who had 213 serial CMRs at a median of 255 days after the index CMR. Of these, 97.2% were anticoagulated. At 3 months after detection by CMR, 75% (47/63) had no resolution of LV thrombus; at 6 months, 53% (35/66) had no resolution; and at 12 months, 37% (23/63) had no resolution. Correlates of no resolution at 6 months included a history of myocardial infarction, LV aneurysm, ischaemic aetiology of cardiomyopathy, and larger thrombus volume. Recurrence of LV thrombus was rare at 5.3%. On survival analysis using the landmark analysis method, embolic events often occurred beyond 6 months, more frequently in patients with unresolved LV thrombus.
Conclusion:
Our findings challenge previous literature by demonstrating a lower rate of resolution of LV thrombus and substantial embolic risk beyond 6 months associated with unresolved LV thrombus on serial CMR. Our findings advocate for extended anticoagulation, particularly in patients with markers associated with no resolution. These findings have important implications for clinical practice and research into managing patients with LV thrombus.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Mitral Regurgitation II: Clinical features and Diagnostic Tests